Cocoa Products Metabolic Syndrome Meta-Analysis Evidence Table

Structured evidence table for Cocoa Products Metabolic Syndrome Meta-Analysis, generated from 1 reusable source document in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Cocoa Products Metabolic Syndrome Meta-AnalysisThe meta-analysis showed a significant effect of cocoa supplementation on triacylglycerol levels (-0.21 mmol/L, 95% CI: -0.40, -0.02; p = 0.0333), and subgroup analysis suggested that cholesterol levels were reduced with cocoa supplementation in patients with dyslipidemia and diabetes.1Gomes Chagas A (2026)The effects of cocoa products in individuals with metabolic syndrome and related diseases: a systematic review and meta-analysis.
Cocoa Products Metabolic Syndrome Meta-AnalysisOur study suggests that cocoa intake has limited evidence of benefit, mainly for triglycerides, furthermore, effects and that the duration, type, and clinical status of patients were important determinants for favorable effects on biomarkers related to metabolic syndrome.1Gomes Chagas A (2026)The effects of cocoa products in individuals with metabolic syndrome and related diseases: a systematic review and meta-analysis.
Cocoa Products Metabolic Syndrome Meta-AnalysisCocoa supplementation has been shown to improve parameters related to metabolic syndrome, although results have been contradictory.1Gomes Chagas A (2026)The effects of cocoa products in individuals with metabolic syndrome and related diseases: a systematic review and meta-analysis.
Cocoa Products Metabolic Syndrome Meta-AnalysisWe conducted a systematic review and meta-analysis to examine the effect of cocoa products on lipid and glycemic profiles, blood pressure levels, and anthropometric measurements in individuals with metabolic syndrome and related diseases.1Gomes Chagas A (2026)The effects of cocoa products in individuals with metabolic syndrome and related diseases: a systematic review and meta-analysis.

Source documents

  1. The effects of cocoa products in individuals with metabolic syndrome and related diseases: a systematic review and meta-analysis.